Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: An update

Drugs of Today

Volumn 54, Issue 2, 2018, Pages 123-136

  Holleran, G ^a,b   Scaldaferri, F ^a   Ianiro, G ^a   Lopetuso, L ^a   Mc Namara, D ^b   Mele, M C ^a   Gasbarrini, A ^a   Cammarota, G ^a  

^a FONDAZIONE POLICLINICO UNIVERSITARIO A GEMELLI IRCCS   (Italy)

^b ADELAIDE AND MEATH HOSPITAL   (Ireland)

Author keywords

Crohn's disease; Fecal microbiota transplantation; Intestinal dysbiosis; Irritable bowel syndrome; Ulcerative colitis

Indexed keywords

ABDOMINAL PAIN; ACTINOBACTERIA; BACTEROIDETES; CLINICAL EFFECTIVENESS; CLOSTRIDIUM DIFFICILE INFECTION; CONSTIPATION; CROHN DISEASE; DIARRHEA; DISEASE ASSOCIATION; DONOR SELECTION; DYSBIOSIS; ENVIRONMENTAL FACTOR; ERUCTATION; FECAL MICROBIOTA TRANSPLANTATION; FECES; FIRMICUTES; GASTROINTESTINAL DISEASE; HUMAN; INTESTINE FLORA; IRRITABLE COLON; MICROBIAL DIVERSITY; NONHUMAN; PATIENT SAFETY; PROTEOBACTERIA; REVIEW; SCREENING TEST; THERAPY EFFECT; TREATMENT OUTCOME; TREATMENT PLANNING; TREATMENT RESPONSE; ULCERATIVE COLITIS; CLOSTRIDIUM INFECTION; ENTEROPATHY; INFLAMMATORY BOWEL DISEASE; MICROBIOLOGY; PROCEDURES;

CLOSTRIDIUM INFECTIONS; COLITIS, ULCERATIVE; DYSBIOSIS; FECAL MICROBIOTA TRANSPLANTATION; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL DISEASES;

EID: 85048105648     PISSN: 16993993     EISSN: 16994019     Source Type: Journal    
DOI: 10.1358/dot.2018.54.2.2760765     Document Type: Review

References (107)

1. Eiseman, B., Silen, W., Bascom, G.S., Kauvar, A.J. Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery 1958, 44(5): 854-9
2. van Nood, E., Vrieze, A., Nieuwdorp, M. et al. Duodenal infusion of donor feces for recurrent Clostridium difficile. N Engl J Med 2013, 368(5): 407-15
3. Cammarota, G., Ianiro, G., Bibbo, S., Gasbarrini, A. Gut microbiota modulation: probiotics, antibiotics or fecal microbiota transplantation? Intern Emerg Med 2014, 9(4): 365-73
4. Cammarota, G., Ianiro, G., Tilg, H. et al. European consensus conference on faecal microbiota transplantation in clinical practice. Gut 2017, 66(4): 569-80
5. Vrieze, A., Van Nood, E., Holleman, F. et al. Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome. Gastroenterology 2012, 143(4): 913-6 e7
6. Xu, M.Q., Cao, H.L., Wang, W.Q., Wang, S., Cao, X.C., Yan, F., Wang, B.M. Fecal microbiota transplantation broadening its application beyond intestinal disorders. World J Gastroenterol 2015, 21(1): 102-11
7. Yatsunenko, T., Rey, F.E., Manary, M.J. et al. Human gut microbiome viewed across age and geography. Nature 2012, 486(7402): 222-7
8. Human Microbiome Project, C. Structure, function and diversity of the healthy human microbiome. Nature 2012, 486(7402): 207-14
9. Chu, H., Khosravi, A., Kusumawardhani, I.P. et al. Gene-microbiota interactions contribute to the pathogenesis of inflammatory bowel disease. Science 2016, 352(6289): 1116-20
10. Harbord, M., Eliakim, R., Bettenworth, D. et al. Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 2: Current Management. J Crohns Colitis 2017, 11(7): 769-84
11. Scaldaferri, F., Gerardi, V., Lopetuso, L.R. et al. Gut microbial flora, prebiotics, and probiotics in IBD: their current usage and utility. Biomed Res Int 2013, 2013: 435268
12. Manichanh, C., Rigottier-Gois, L., Bonnaud, E. et al. Reduced diversity of faecal microbiota in Crohn's disease revealed by a metagenomic approach. Gut 2006, 55(2): 205-11
13. Frank, D.N., Robertson, C.E., Hamm, C.M. et al. Disease phenotype and genotype are associated with shifts in intestinal-associated microbiota in inflammatory bowel diseases. Inflamm Bowel Dis 2011, 17(1): 179-84
14. Rajilic-Stojanovic, M., Shanahan, F., Guarner, F., de Vos, W.M. Phylogenetic analysis of dysbiosis in ulcerative colitis during remission. Inflamm Bowel Dis 2013, 19(3): 481-8
15. Rehman, A., Lepage, P., Nolte, A., Hellmig, S., Schreiber, S., Ott, S.J. Transcriptional activity of the dominant gut mucosal microbiota in chronic inflammatory bowel disease patients. J Med Microbiol 2010, 59(Pt 9): 1114-22
16. Kleessen, B., Kroesen, A.J., Buhr, H.J., Blaut, M. Mucosal and invading bacteria in patients with inflammatory bowel disease compared with controls. Scand J Gastroenterol 2002, 37(9): 1034-41
17. Lavelle, A., Lennon, G., O'Sullivan, O. et al. Spatial variation of the colonic microbiota in patients with ulcerative colitis and control volunteers. Gut 2015, 64(10): 1553-61
18. Bennet, J.D., Brinkman, M. Treatment of ulcerative colitis by implantation of normal colonic flora. Lancet 1989, 1(8630): 164
19. Scaldaferri, F., Pecere, S., Bruno, G. An open-label, pilot study to assess feasibility and safety of fecal microbiota transplantation in patients with mild-moderate ulcerative colitis: Preliminary results. J Crohns Colitis 2015, 9(Suppl 1): S278
20. Borody, T.J., George, L., Andrews, P. et al. Bowel-flora alteration: a potential cure for inflammatory bowel disease and irritable bowel syndrome? Med J Aust 1989, 150(10): 604
21. Nishida, A., Imaeda, H., Ohno, M., Inatomi, O., Bamba, S., Sugimoto, M., Andoh, A. Efficacy and safety of single fecal microbiota transplantation for Japanese patients with mild to moderately active ulcerative colitis. J Gastroenterol 2017, 52(4): 476-82
22. Jacob, V., Crawford, C., Cohen-Mekelburg, S. Fecal microbiota transplantation via colonoscopy is safe and effective in active ulcerative colitis. Adv Inflamm Bowel Dis (Dec 8-10, Orlando) 2017
23. Zhang, T., Cui, B., Li, P. et al. Short-term surveillance of cytokines and C-reactive protein cannot predict efficacy of fecal microbiota transplantation for ulcerative colitis. PLoS One 2016, 11(6): e0158227
24. Paramsothy, S., Paramsothy, R., Rubin, D.T., Kamm, M.A., Kaakoush, N.O., Mitchell, H.M., Castano- Rodriguez, N. Faecal microbiota transplantation for inflammatory bowel disease: A systematic review and meta-analysis. J Crohns Colitis 2017, 11(10): 1180-99
25. Costello, S.P., Soo, W., Bryant, R.V., Jairath, V., Hart, A.L., Andrews, J.M. Systematic review with metaanalysis: faecal microbiota transplantation for the induction of remission for active ulcerative colitis. Aliment Pharmacol Ther 2017, 46(3): 213-24
26. Shi, Y., Dong, Y., Huang, W., Zhu, D., Mao, H., Su, P. Fecal microbiota transplantation for ulcerative colitis: A systematic review and meta-analysis. PLoS One 2016, 11(6): e0157259
27. Rutgeerts, P., Sandborn, W.J., Feagan, B.G. et al. Infliximab for induction and maintenance therapy for ulcerative colitis. N Engl J Med 2005, 353(23): 2462-76
28. Colombel, J.F., Sandborn, W.J., Ghosh, S. et al. Fouryear maintenance treatment with adalimumab in patients with moderately to severely active ulcerative colitis: Data from ULTRA 1, 2, and 3. Am J Gastroenterol 2014, 109(11): 1771-80
29. Sandborn, W.J., Feagan, B.G., Marano, C. et al. Subcutaneous golimumab induces clinical response and remission in patients with moderate-to-severe ulcerative colitis. Gastroenterology 2014, 146(1): 85-95
30. Feagan, B.G., Rutgeerts, P., Sands, B.E. et al. Vedolizumab as induction and maintenance therapy for ulcerative colitis. N Engl J Med 2013, 369(8): 699-710
31. Paramsothy, S., Kamm, M.A., Kaakoush, N.O. et al. Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Lancet 2017, 389(10075): 1218-28
32. Costello, S., Waters, O., Bryant, R. et al. Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial. J Crohns Colitis 2017, 11(Suppl 1): S23
33. Moayyedi, P., Surette, M.G., Kim, P.T. et al. Fecal microbiota transplantation induces remission in patients with active ulcerative colitis in a randomized controlled trial. Gastroenterology 2015, 149(1): 102-9 e6
34. Rossen, N.G., Fuentes, S., van der Spek, M.J. et al. Findings from a randomized controlled trial of fecal transplantation for patients with ulcerative colitis. Gastroenterology 2015, 149(1): 110-8 e4
35. Narula, N., Kassam, Z., Yuan, Y., Colombel, J.F., Ponsioen, C., Reinisch, W., Moayyedi, P. Systematic review and meta-analysis: Fecal -microbiota transplantation for treatment of active ulcerative colitis. Inflamm Bowel Dis 2017, 23(10): 1702-9
36. Kassam, Z., Lee, C.H., Yuan, Y., Hunt, R.H. Fecal microbiota transplantation for Clostridium difficile infection: systematic review and meta-analysis. Am J Gastroenterol 2013, 108(4): 500-8
37. Kummen, M., Holm, K., Anmarkrud, J.A. et al. The gut microbial profile in patients with primary sclerosing cholangitis is distinct from patients with ulcerative colitis without biliary disease and healthy controls. Gut 2017, 66(4): 611-9
38. Sokol, H. Toward rational donor selection in faecal microbiota transplantation for IBD. J Crohns Colitis 2016, 10(4): 375-6
39. Sokol, H., Galperine, T., Kapel, N. et al. Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation. Dig Liver Dis 2016, 48(3): 242-7
40. Browne, H.P., Forster, S.C., Anonye, B.O. et al. Culturing of 'unculturable' human microbiota reveals novel taxa and extensive sporulation. Nature 2016, 533(7604): 543-6
41. Sokol, H., Seksik, P., Furet, J.P. et al. Low counts of Faecalibacterium prausnitzii in colitis microbiota. Inflamm Bowel Dis 2009, 15(8): 1183-9
42. Flores, R., Shi, J., Yu, G., Ma, B., Ravel, J., Goedert, J.J., Sinha, R. Collection media and delayed freezing effects on microbial composition of human stool. Microbiome 2015, 3(1): 33
43. Lee, C.H., Steiner, T., Petrof, E.O. et al. Frozen vs fresh fecal microbiota transplantation and clinical resolution of diarrhea in patients with recurrent Clostridium difficile infection: A randomized clinical trial. JAMA 2016, 315(2): 142-9
44. Jalanka, J., Salonen, A., Salojarvi, J. et al. Effects of bowel cleansing on the intestinal microbiota. Gut 2015, 64(10): 1562-8
45. Harrell, L., Wang, Y., Antonopoulos, D. et al. Standard colonic lavage alters the natural state of mucosalassociated microbiota in the human colon. PLoS One 2012, 7(2): e32545
46. Drago, L., Toscano, M., De Grandi, R., Casini, V., Pace, F. Persisting changes of intestinal microbiota after bowel lavage and colonoscopy. Eur J Gastroenterol Hepatol 2016, 28(5): 532-7
47. Gilat, T., Leichtman, G., Delpre, G., Eshchar, J., Bar Meir, S., Fireman, Z. A comparison of metronidazole and sulfasalazine in the maintenance of remission in patients with ulcerative colitis. J Clin Gastroenterol 1989, 11(4): 392-5
48. Nitzan, O., Elias, M., Peretz, A., Saliba, W. Role of antibiotics for treatment of inflammatory bowel disease. World J Gastroenterol 2016, 22(3): 1078-87
49. Ishikawa, D., Sasaki, T., Osada, T. et al. Changes in intestinal microbiota following combination therapy with fecal microbial transplantation and antibiotics for ulcerative colitis. Inflamm Bowel Dis 2017, 23(1): 116-25
50. Wei, Y., Gong, J., Zhu, W. et al. Pectin enhances the effect of fecal microbiota transplantation in ulcerative colitis by delaying the loss of diversity of gut flora. BMC Microbiol 2016, 16(1): 255
51. Cammarota, G., Ianiro, G., Gasbarrini, A. Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review. J Clin Gastroenterol 2014, 48(8): 693-702
52. Drekonja, D., Reich, J., Gezahegn, S. et al. Fecal microbiota transplantation for Clostridium difficile infection: A systematic review. Ann Intern Med 2015, 162(9): 630-8
53. Cammarota, G., Ianiro, G., Magalini, S., Gasbarrini, A., Gui, D. Decrease in surgery for Clostridium difficile infection after starting a program to transplant fecal microbiota. Ann Intern Med 2015, 163(6): 487-8
54. Fischer, M., Sipe, B.W., Rogers, N.A., Cook, G.K., Robb, B.W., Vuppalanchi, R., Rex, D.K. Faecal microbiota transplantation plus selected use of vancomycin for severe-complicated Clostridium difficile infection: description of a protocol with high success rate. Aliment Pharmacol Ther 2015, 42(4): 470-6
55. Fischer, M., Kao, D., Mehta, S.R. et al. Predictors of early failure after fecal microbiota transplantation for the therapy of Clostridium difficile infection: A multicenter study. Am J Gastroenterol 2016, 111(7): 1024-31
56. Damman, C.J., Miller, S.I., Surawicz, C.M., Zisman, T.L. The microbiome and inflammatory bowel disease: is there a therapeutic role for fecal microbiota transplantation? Am J Gastroenterol 2012, 107(10): 1452-9
57. Allegretti, J.R., Fischer, M., Papa, E. et al. Fecal microbiota transplantation delivered via oral capsules achieves microbial engraftment similar to traditional delivery modalities: Safety, efficacy and engraftment results from a multi-center cluster randomized dose-finding study. Gastroenterology 2016, 150(4): S540
58. Youngster, I., Mahabamunuge, J., Systrom, H.K. et al. Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection. BMC Med 2016, 14(1): 134
59. Debast, S.B., Bauer, M.P., Kuijper, E.J., European Society of Clinical Microbiology and Infectious Diseases. European Society of Clinical Microbiology and Infectious Diseases: update of the treatment guidance document for Clostridium difficile infection. Clin Microbiol Infect 2014, 20 Suppl 2: 1-26
60. D'Haens, G., Sandborn, W.J., Feagan, B.G. et al. A review of activity indices and efficacy end points for clinical trials of medical therapy in adults with ulcerative colitis. Gastroenterology 2007, 132(2): 763-86
61. Cui, B., Li, P., Xu, L. et al. Step-up fecal microbiota transplantation strategy: a pilot study for steroid-dependent ulcerative colitis. J Transl Med 2015, 13(1): 298
62. Angelberger, S., Reinisch, W., Makristathis, A. et al. Temporal bacterial community dynamics vary among ulcerative colitis patients after fecal microbiota transplantation. Am J Gastroenterol 2013, 108(10): 1620-30
63. Damman, C.J., Brittnacher, M.J., Westerhoff, M. et al. Low level engraftment and improvement following a single colonoscopic administration of fecal microbiota to patients with ulcerative colitis. PLoS One 2015, 10(8): e0133925
64. Kump, P.K., Grochenig, H.P., Lackner, S. et al. Alteration of intestinal dysbiosis by fecal microbiota transplantation does not induce remission in patients with chronic active ulcerative colitis. Inflamm Bowel Dis 2013, 19(10): 2155-65
65. Lepage, P., Seksik, P., Sutren, M., de la Cochetiere, M.F., Jian, R., Marteau, P., Dore, J. Biodiversity of the mucosaassociated microbiota is stable along the distal digestive tract in healthy individuals and patients with IBD. Inflamm Bowel Dis 2005, 11(5): 473-80
66. Smits, L.P., Bouter, K.E., de Vos, W.M., Borody, T.J., Nieuwdorp, M. Therapeutic potential of fecal microbiota transplantation. Gastroenterology 2013, 145(5): 946-53
67. Kelly, C.R., Ihunnah, C., Fischer, M. et al. Fecal microbiota transplant for treatment of Clostridium difficile infection in immunocompromised patients. Am J Gastroenterol 2014, 109(7): 1065-71
68. Frank, J., Högenauer, C., Gröchenig, H.P. Safety of fecal microbiota transplantation in patients with chronic colitis and immunosuppressive treatement. J Crohns Colitis 2015, 9(Suppl 1): S245-S6
69. Brandt, L.J., Aroniadis, O.C., Mellow, M. et al. Longterm follow-up of colonoscopic fecal microbiota transplant for recurrent Clostridium difficile infection. Am J Gastroenterol 2012, 107(7): 1079-87
70. Joossens, M., Huys, G., Cnockaert, M. et al. Dysbiosis of the faecal microbiota in patients with Crohn's disease and their unaffected relatives. Gut 2011, 60(5): 631-7
71. Willing, B., Halfvarson, J., Dicksved, J. et al. Twin studies reveal specific imbalances in the mucosa-associated microbiota of patients with ileal Crohn's disease. Inflamm Bowel Dis 2009, 15(5): 653-60
72. Modi, S.R., Lee, H.H., Spina, C.S., Collins, J.J. Antibiotic treatment expands the resistance reservoir and ecological network of the phage metagenome. Nature 2013, 499(7457): 219-22
73. van Loo, E.S., Dijkstra, G., Ploeg, R.J., Nieuwenhuijs, V.B. Prevention of postoperative recurrence of Crohn's disease. J Crohns Colitis 2012, 6(6): 637-46
74. Manosa, M., Cabre, E., Bernal, I. et al. Addition of metronidazole to azathioprine for the prevention of postoperative recurrence of Crohn's disease: a randomized, double-blind, placebo-controlled trial. Inflamm Bowel Dis 2013, 19(9): 1889-95
75. Cui, B., Feng, Q., Wang, H. et al. Fecal microbiota transplantation through mid-gut for refractory Crohn's disease: safety, feasibility, and efficacy trial results. J Gastroenterol Hepatol 2015, 30(1): 51-8
76. Vermeire, S., Joossens, M., Verbeke, K. et al. Donor species richness determines faecal microbiota transplantation success in inflammatory bowel disease. J Crohns Colitis 2016, 10(4): 387-94
77. Vaughn, B.P., Vatanen, T., Allegretti, J.R. et al. Increased intestinal microbial diversity following fecal microbiota transplant for active Crohn's disease. Inflamm Bowel Dis 2016, 22(9): 2182-90
78. Kahn, S.A., Goeppinger, S.R., Vaughn, B.P., Moss, A.C., Rubin, D.T. Tolerability of colonoscopic fecal microbiota transplantation in IBD. Gastroenterology 2014, 146(5): S-581
79. Suskind, D.L., Brittnacher, M.J., Wahbeh, G. et al. Fecal microbial transplant effect on clinical outcomes and fecal microbiome in active Crohn's disease. Inflamm Bowel Dis 2015, 21(3): 556-63
80. Kao, D., Hotte, N., Gillevet, P., Madsen, K. Fecal microbiota transplantation inducing remission in Crohn's colitis and the associated changes in fecal microbial profile. J Clin Gastroenterol 2014, 48(7): 625-8
81. Drossman, D.A., Hasler, W.L. Rome IV-Functional GI disorders: Disorders of gut-brain interaction. Gastroenterology 2016, 150(6): 1257-61
82. Tap, J., Derrien, M., Tornblom, H. et al. Identification of an intestinal microbiota signature associated with severity of irritable bowel syndrome. Gastroenterology 2017, 152(1): 111-23 e8
83. Simren, M., Barbara, G., Flint, H.J. et al. Intestinal microbiota in functional bowel disorders: a Rome foundation report. Gut 2013, 62(1): 159-76
84. Hungin, A.P., Becher, A., Cayley, B. et al. Irritable bowel syndrome: an integrated explanatory model for clinical practice. Neurogastroenterol Motil 2015, 27(6): 750-63
85. O'Mahony, L., McCarthy, J., Kelly, P. et al. Lactobacillus and Bifidobacterium in irritable bowel syndrome: Symptom responses and relationship to cytokine profiles. Gastroenterology 2005, 128(3): 541-51
86. Halmos, E.P., Power, V.A., Shepherd, S.J., Gibson, P.R., Muir, J.G. A diet low in FODMAPs reduces symptoms of irritable bowel syndrome. Gastroenterology 2014, 146(1): 67-75 e5
87. Johnsen, P.H., Hilpusch, F., Cavanagh, J.P., Leikanger, I.S., Kolstad, C., Valle, P.C., Goll, R. Faecal microbiota transplantation versus placebo for moderate-to-severe irritable bowel syndrome: a double-blind, randomised, placebo-controlled, parallel-group, single-centre trial. Lancet Gastroenterol Hepatol 2018, 3(1): 17-24
88. Halkjaer, S.I., Boolsen, A.W., Gunther, S., Christensen, A.H., Petersen, A.M. Can fecal microbiota transplantation cure irritable bowel syndrome? World J Gastroenterol 2017, 23(22): 4112-20
89. Pinn, D.M., Aroniadis, O.C., Brandt, L.J. Follow-up study of fecal microbiota transplantation (FMT) for the treatment of refractory irritable bowel syndrome (IBS). Am J Gastroenterol 2013, 108: S563
90. Holvoet, T., Boelens, J., Joossens, M., Raes, J., De Vos, M., De Looze, D. Fecal microbiota transplantation in irritable bowel syndrome with bloating: Results from a prospective pilot study. Gastroenterology 2015, 148(4): S-963-S-4
91. Cruz Aguilar, R., Buch, T., Bajbouj, M. Fecal microbiota transplantation as a novel therapy for irritable bowel syndrome with predominant diarrhea. Neurogastroenterol Motil 2015, 27(Suppl 2): 110
92. Hong, J., Bang, B., Shin, Y., Kim, H., Kwon, K. Treatment of irritable bowel syndrome with fecal microbiota transplantation: A case series of 10 patients. Unit Eur Gastroenterol J 2016, 2(Suppl 1): OP257
93. Syzenko, G., Budovska, L., Puchkov, K. Efficiency of FMT in cases of 'Treatment-resistant' IBS. Unit Eur Gastroenterol J 2016, 2(Suppl 1): P0397
94. Mazzawi, T., Lied, G., El-Salhy, M., Gilja, O., Hatlebakk, J., Hausken, T. Effect of faecal microbiota transplantation on symptoms and duodenal enteroendocrine cells in patients with irritable bowel syndrome. Unit Eur Gastroenterol J 2016, 2(Suppl 1): P1527
95. Patel, S.M., Stason, W.B., Legedza, A. et al. The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol Motil 2005, 17(3): 332-40
96. Mizuno, S., Masaoka, T., Naganuma, M. et al. Bifidobacterium-Rich Fecal Donor May Be a Positive Predictor for Successful Fecal Microbiota Transplantation in Patients with Irritable Bowel Syndrome. Digestion 2017, 96(1): 29-38
97. Hawrelak, J.A., Myers, S.P. The causes of intestinal dysbiosis: a review. Altern Med Rev 2004, 9(2): 180-97
98. Walker, A.W., Lawley, T.D. Therapeutic modulation of intestinal dysbiosis. Pharmacol Res 2013, 69(1): 75-86
99. Ghoshal, U.C., Shukla, R., Ghoshal, U., Gwee, K.A., Ng, S.C., Quigley, E.M. The gut microbiota and irritable bowel syndrome: friend or foe? Int J Inflam 2012, 2012: 151085
100. Lin, H.C. Small intestinal bacterial overgrowth: a framework for understanding irritable bowel syndrome. JAMA 2004, 292(7): 852-8
101. Pyleris, E., Giamarellos-Bourboulis, E.J., Tzivras, D., Koussoulas, V., Barbatzas, C., Pimentel, M. The prevalence of overgrowth by aerobic bacteria in the small intestine by small bowel culture: relationship with irritable bowel syndrome. Dig Dis Sci 2012, 57(5): 1321-9
102. Rosania, R., Giorgio, F., Principi, M., Amoruso, A., Monno, R., Di Leo, A., Ierardi, E. Effect of probiotic or prebiotic supplementation on antibiotic therapy in the small intestinal bacterial overgrowth: a comparative evaluation. Curr Clin Pharmacol 2013, 8(2): 169-72
103. Barbara, G., Scaioli, E., Barbaro, M.R. et al. Gut microbiota, metabolome and immune signatures in patients with uncomplicated diverticular disease. Gut 2017, 66(7): 1252-61
104. Kvasnovsky, C.L., Leong, L.E.X., Choo, J.M., Abell, G.C.J., Papagrigoriadis, S., Bruce, K.D., Rogers, G.B. Clinical and symptom scores are significantly correlated with fecal microbiota features in patients with symptomatic uncomplicated diverticular disease: a pilot study. Eur J Gastroenterol Hepatol 2018, 30(1): 107-12
105. Lahner, E., Bellisario, C., Hassan, C., Zullo, A., Esposito, G., Annibale, B. Probiotics in the treatment of diverticular disease. A systematic review. J Gastrointestin Liver Dis 2016, 25(1): 79-86
106. Lahtinen, P., Mattila, E., Anttila, V.J. et al. Faecal microbiota transplantation in patients with Clostridium difficile and significant comorbidities as well as in patients with new indications: A case series. World J Gastroenterol 2017, 23(39): 7174-84
107. Qin, J., Li, R., Raes, J. et al. A human gut microbial gene catalogue established by metagenomic sequencing. Nature 2010, 464(7285): 59-65.